Neil Dahiya

We have submitted an application to renew the registration of the Ethics Committee (EC) with the relevant authorities. The EC, however, has yet to receive confirmation of renewal from these authorities. Is it permissible for the EC to proceed with […]

The pharmaceutical sector functions within a highly regulated sphere, requiring firms to skillfully traverse a labyrinth of international regulations for their products to reach the global market. While these regulations prioritize the safety, efficacy, and quality of medications, they also

In an effort to nurture the budding medical devices sector within the nation, the central government has initiated a scheme titled ‘Enhancement of Medical Device Industry,’ earmarking an initial fund of Rs. 500 crore across three years from 2024-25 to

The United Kingdom and the Republic of Korea have joined forces in a fresh alliance that seeks to accelerate, optimize, and enhance the productivity of clinical trials. The objective is to establish quicker, more efficient, and fairer pathways to safe

Haemonetics Corporation, a leading player in medical technology specializing in breakthrough healthcare solutions for enhanced patient outcomes, has disclosed a definitive pact to divest its whole blood assets to GVS, S.p.A (GVS). GVS stands as a prominent manufacturer of filtration

To fortify its defenses against a potential H5 influenza pandemic, the UK Government has secured a contract for upwards of five million doses of the H5 influenza vaccine. This strategic move aims to bolster the nation’s resilience and preparedness. The

In response to the tragic deaths of four expectant mothers who were given below-standard Ringer’s lactate solution—an intravenous fluid typically administered to restore hydration and electrolyte equilibrium—the Karnataka government has decided to suspend Dr. Umesh S., the state’s drugs controller,

The updated guidelines released on May 1 by the National Commission for Indian System of Medicine (NCISM) to evaluate and govern the minimum standards and criteria (MSR) applicable to self-supporting Ayurveda educational institutions and their affiliated hospitals will not entirely

The Health and Family Welfare Department of Karnataka has urged the Drugs Controller General of India (DCGI) to swiftly investigate and address the issue of substandard Ringer’s lactate IV infusion fluid supplied by Paschim Banga Pharmaceutical, a West Bengal company.

Over the past five years, the Pharmaceuticals & Medical Devices Bureau of India (PMBI), overseen by the Department of Pharmaceuticals (DoP), has prohibited six pharmaceutical suppliers from providing medications to Jan Aushadhi Kendras (JAKs) due to their failure to adhere